Filters

117 Results

relevance


Excedrin Migraine Pain Relief

Ad Alert

Excedrin Migraine Pain Relief

A reader submitted a tip concerning the pricing of Excedrin Migraine Pain Reliever versus Excedrin Extra Strength Pain Reliever.

Doggie Dailies

Ad Alert

Doggie Dailies

Dog supplement manufacturer makes changes to Amazon listing following TINA.org inquiry.

Neurolumen

Ad Alert

Neurolumen

Brochure for medical device targeted military members with illegal claims to treat PTSD, among other diseases.

The Willow Curve

Ad Alert

The Willow Curve

Futuristic-looking device promises relief from nerve and joint pain but clinical trials appear to be lacking.

Nerve Pain Away

Ad Alert

Nerve Pain Away

Homeopathic spray becomes the first to adopt disclosure admitting lack of scientific evidence.

Y. S. Health Corp

Ad Alert

Y. S. Health Corp

The FDA has issued a warning letter to Y.S. Health Corp for making drug claims in violation of the Food, Drug, and Cosmetic Act. Y.S. Health Corp is also under…

Tommie Copper

Ad Alert

Tommie Copper

Company agrees to pay $1.35 million to settle deceptive advertising charges about its copper-infused compression clothing.

Emu Product Claims Questioned by FDA

Ad Alert

Emu Product Claims Questioned by FDA

Emu Products and Management, Inc. claimed on its website that its products could treat health problems including acne, arthritis, and high cholesterol. According to a warning letter from the FDA,…

Supple

Ad Alert

Supple

FTC slaps former couple that sold supplement drink for misleading consumers.

Aspercreme

Ad Alert

Aspercreme

TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.

Show More